Kazuyuki Tomisawa - Concepedia

Author

Kazuyuki Tomisawa

Also Known As

K Tomisawa, K. TOMISAWA, K. Tomisawa, KAZUYUKI TOMISAWA, Kazuyuki TOMISAWA, Kazuyuki Tomisawa, Kei TOMISAWA, Tomisawa, K.

Publications

979

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Nihon Nohyaku (Japan)

About

Kazuyuki Tomisawa is an author at Taisho Pharmaceutical (Japan) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	16	533
2	Natural Sciences	5	5	94
3	Social Sciences	5	5	186
4	Health Sciences	3	3	141
5	Engineering	1	1	21

Kazuyuki Tomisawa

Publications

866

Citations

H-Index

Page 1

	Year	Citations
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001 Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima, Journal of Pharmacology and Experimental Therapeutics	1999	153
Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106 Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa, Life Sciences Molecular PharmacologyNeuropharmacological ProfileNeurophysiologyMedicinePsychotropic Medication	1999	90
Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet Shigeru Murakami, Yukiko Kondo-Ohta, Kazuyuki Tomisawa Life Sciences Metabolic SyndromeCholesterol MetabolismOxysterolHealth SciencesLipid Nutrition	1998	87
Binding characteristics of DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors Shigeyuki Chaki, Takeo Funakoshi, Ryoko Yoshikawa, European Journal of Pharmacology Drug TargetBiochemistryFunctional SelectivityPeripheral Benzodiazepine ReceptorsMedicine	1999	80
Inhibition of Gastric H <sup>+</sup> ,K <sup>+</sup> -ATPase by Flavonoids: A Structure-Activity Study Shigeru Murakami, Makoto Muramatsu, Kazuyuki Tomisawa Journal of enzyme inhibition	1999	50
The atypical antipsychotic profile of NRA0045, a novel dopamine D<sub>4</sub> and 5‐hydroxytryptamine<sub>2A</sub> receptor antagonist, in rats Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima, British Journal of Pharmacology	1997	42
Regulation of NMDA-induced [3H] dopamine release from rat hippocampal slices through sigma-1 binding sites Shigeyuki Chaki, Shigeru Okuyama, Shinichi Ogawa, Neurochemistry International Rat Hippocampal SlicesNeurophysiologyMedicineMolecular SubstrateNeuropharmacology	1998	37
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001 Shigeyuki Chaki, Shigeru Okuyama, Atsuro Nakazato, European Journal of Pharmacology Signal TransductionMedicineImmunologyMechanism Of ActionReceptor (Biochemistry)	1999	35
Studies on antirheumatic agents. 3-Benzoylpropionic acid derivatives. Kazuya Kameo, Kunio Ogawa, Kimiyo Takeshita, Chemical and Pharmaceutical Bulletin Medicinal ChemistryPharmaceutical ScienceDerivativesDerivative (Chemistry)Biochemistry	1988	35
Prevention of atherosclerotic lesion development in mice by taurine. Shigeru Murakami, Yasuhiko Kondo, Kazuyuki Tomisawa, PubMed Atherosclerotic Lesion DevelopmentImmunologyHyperlipidemiaHigh-fat DietOxidative Stress	1999	31

Page 1